Serum albumin has attracted significant attention as a drug‐delivery carrier to tumor tissue. We previously reported boron neutron capture therapy (BNCT), an effective method that uses maleimide‐functionalized closo‐dodecaborate albumin conjugates (MID‐ACs). MID can form covalent bonds with the free thiol group of Cys34 and with lysine residues in albumin. In this study, we synthesized tyrosyl‐radical‐trapping‐moiety‐functionalized closo‐dodecaborates (TRT‐DBs), which were expected to form covalent bonds with tyrosine residues. N′‐Acetyl‐N,N‐dimethylphenylenediamine was chosen as the TRT moiety to bind to closo‐dodecaborate through an amide linker (TRT‐DB 1) and an ammonium linker (TRT‐DB 2). TRT‐DB 1 more efficiently conjugated to bovine serum albumin (BSA) than 2: approximately 2.4 molecules of 1 were bound to each BSA if BSA (10 µm) was treated with 1 (1 mm) in the presence of Ru(bpy)3 (1 mm; bpy = 2,2′‐bipyridyl) and ammonium persulfate (1 mm) under light irradiation for 1 min. Furthermore, double modification of BSA with 1 and MID increased the boron density in BSA for efficient boron delivery to tumors. Western blot analysis using the anti‐B12 cluster antibody revealed that closo‐dodecaborate‐conjugated BSAs were taken up by colon 26 cells.
Read full abstract